VIKING THERAPEUT.DL -,005VIKING THERAPEUT.DL -,005VIKING THERAPEUT.DL -,005

VIKING THERAPEUT.DL -,005

No trades
See on Supercharts
Market capitalization
‪6.81 B‬EUR
−0.82EUR
‪−77.82 M‬EUR
‪100.41 M‬
Beta (1Y)
2.75

About VIKING THERAPEUT.DL -,005

CEO
Brian Lian
Headquarters
San Diego
Employees (FY)
27
Founded
2012
ISIN
US92686J1060
FIGI
BBG008MYSTS9
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange VIKING THERAPEUT.DL -,005 stocks are traded under the ticker 1VT.
VIKING THERAPEUT.DL -,005 is going to release the next earnings report on Apr 24, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for VIKING THERAPEUT.DL -,005 has a max estimate of 127.36 EUR and a min estimate of 83.06 EUR.
1VT earnings for the last quarter are −0.22 EUR whereas the estimation was −0.21 EUR which accounts for −5.00% surprise. Estimated earnings for the next quarter are −0.23 EUR. See more details about VIKING THERAPEUT.DL -,005 earnings.
Yes, you can track VIKING THERAPEUT.DL -,005 financials in yearly and quarterly reports right on TradingView.
1VT net income for the last quarter is ‪−22.29 M‬ EUR, while the quarter before that showed ‪−21.32 M‬ EUR of net income which accounts for −4.58% change. Track more VIKING THERAPEUT.DL -,005 financial stats to get the full picture.
No, 1VT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 1VT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIKING THERAPEUT.DL -,005 stock right from TradingView charts — choose your broker and connect to your account.
1VT reached its all-time high on Feb 28, 2024 with the price of 91.50 EUR, and its all-time low was 0.78 EUR and was reached on Aug 3, 2017.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 27.00 employees. See our rating of the largest employees — is VIKING THERAPEUT.DL -,005 on this list?
We've gathered analysts' opinions on VIKING THERAPEUT.DL -,005 future price: according to them, 1VT price has a max estimate of 127.35 EUR and a min estimate of 83.06 EUR. Read a more detailed VIKING THERAPEUT.DL -,005 forecast: see what analysts think of VIKING THERAPEUT.DL -,005 and suggest that you do with its stocks.